Grifols, a global manufacturer of plasma-based medicines headquartered in Barcelona, Spain, held a celebration to mark 50 years in Clayton, NC. Grifols acquired the Johnston County facility in 2011 ...

Company approved measures to bolster corporate governance Short seller Gotham City has questioned the firm’s governance Grifols SA’s board of directors plans to expand its annual self-review following ...

Grifols reveals earnings for Q1 on May 14. Wall Street analysts are expecting earnings per share of $0.106. Follow Grifols stock price in real-time on Markets Insider here. On May 14, Grifols will ...

BARCELONA (Reuters) – Spanish drugmaker Grifols swung to a first-quarter net profit of 21 million euros ($23 million) from a year-ago loss, and said on Tuesday it was on track to meet its 2024 outlook ...

Arboviruses are a growing emerging threat, with changes in climate and increasing global connectivity making the geographic spread more prevalent CE mark for Grifols’ Procleix ArboPlex Assay ...

At close: May 14 at 10:28 AM EDT ...

View upcoming earnings forecasts and in-depth analysis of company forecasts.

Hologic and Grifols have worked together since 1998 building a blood screening business, and now Hologic will sell its share to Grifols. Hologic and Grifols have worked together since 1998 ...

Grifols, a global biotherapeutics company with major operations in North Carolina, has begun producing the first specific COVID-19 drug at its manufacturing campus in Clayton. The company is producing ...